Northcott John
- SEC CIK
- 0001615000
No open-market purchases or sales filed in the past year.
Current role at each company
- NKTR Nektar TherapeuticsSVP & Chief Commercial Officeras of May 17, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Northcott John as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 17, 2022 (view filing) | May 16 | 1 day | Northcott JohnSVP & Chief Commercial Officer | SSale | −4.59K | $3.95 | −$18.1K | −2.0%223.2K after | |
| Feb 18, 2022 (view filing) | Feb 16 | 2 days | Northcott JohnSVP & Chief Commercial Officer | SSale | −4.85K | $10.95 | −$53.1K | −2.1%227.8K after | |
| Nov 17, 2021 (view filing) | Nov 16 | 1 day | Northcott JohnSVP & Chief Commercial Officer | SSale | −6.06K | $13.16 | −$79.8K | −3.0%194.9K after | |
| Aug 18, 2021 (view filing) | Aug 16 | 2 days | Northcott JohnSVP & Chief Commercial Officer | SSale | −6.19K | $13.83 | −$85.6K | −3.0%200.9K after |